Large cohort studies have shown no increased risk compared to other metabolic medications (Douros et al., 2025)
Always a simple process So easy to reorder every time
Oussaada SM, van Galen KA, Cooiman MI, Kleinendorst L, Hazebroek EJ, van Haelst MM, et al
It mimics endogenous GLP-1 with 94% homology but with extended half-life (~165 hours) due to albumin binding via a C-18 fatty di-acid side chain
Their active ingredient, semaglutide, belongs to a class of GLP-1 receptor agonists that work to reduce weight by mimicking a naturally occurring hormone that signals your body to feel full and slows digestion by increasing the time it takes for food to leave the body
Wegovy doses reach up to 7.2 mg, although 2.4 mg is the usual maintenance dose, and unlike Ozempic, it is licensed for weight loss in the UK